Annovis Bio, Inc. (FRA:07X)

Annovis Bio Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 26, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	103	67	174	103	125	42
Market Cap Growth	6.35%	-61.39%	69.23%	-18.07%	194.78%	-
Enterprise Value	90	55	168	73	83	35
Last Close Price	3.97	4.96	18.00	12.14	15.80	5.30
PB Ratio	9.17	7.46	-24.76	3.87	3.20	6.89
P/TBV Ratio	9.17	7.46	-	3.87	3.20	6.89
Quick Ratio	4.09	2.72	1.35	3.69	30.33	13.96
Current Ratio	4.60	3.59	2.39	4.68	30.54	14.04
Return on Equity (ROE)	-246.14%	-3159.09%	-546.40%	-69.57%	-55.68%	-180.82%
Return on Assets (ROA)	-105.88%	-138.26%	-121.77%	-38.88%	-33.58%	-89.86%
Return on Capital (ROIC)	-165.21%	-2143.41%	-273.63%	-43.79%	-34.92%	-126.89%
Return on Capital Employed (ROCE)	-198.60%	-265.80%	-759.60%	-90.10%	-32.70%	-88.10%
Earnings Yield	-20.63%	-35.43%	-29.29%	-23.10%	-10.17%	-10.51%
Buyback Yield / Dilution	-61.36%	-35.60%	-10.55%	-7.03%	-20.88%	-2132.36%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.